"","中等症持続型／2-5歳／n=14(%)","中等症持続型／6-15歳／n=1102(%)","中等症持続型／16-35歳／n=2146(%)","中等症持続型／36-55歳／n=3816(%)","中等症持続型／56-75歳／n=2938(%)","中等症持続型／76歳以上／n=851(%)","重症持続型／2-5歳／n=3(%)","重症持続型／6-15歳／n=88(%)","重症持続型／16-35歳／n=292(%)","重症持続型／36-55歳／n=723(%)","重症持続型／56-75歳／n=688(%)","重症持続型／76歳以上／n=228(%)"
"β2刺激薬の使用状況","28.6","48.6","66.5","72.3","71.6","66.6","100.0","75.0","80.1","84.1","83.4","79.4"
